Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FDQEC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,234
Award facts
- Contract value 100% obligated
- $3,234.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,234.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of November 21, 2025. This award was issued on October 30, 2025, and represents one of numerous delivery orders DMS Pharmaceutical Group has received from DLA's Medical Supply Chain division in recent months.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency—the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative—which carries a $499.9 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V is part of a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. Through this IDC framework, DMS Pharmaceutical Group serves as a critical supplier to military medical operations, with its established performance on delivery orders demonstrating capability to meet the diverse pharmaceutical requirements of the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FDQEC?
SPE2DB26FDQEC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FDQEC worth?
The government has obligated $3,234 on SPE2DB26FDQEC.
Is contract SPE2DB26FDQEC an order under another contract?
Yes. SPE2DB26FDQEC is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB26FDQEC competed?
The extent of competition for SPE2DB26FDQEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award